Planmeca Oy Planning to Acquire KaVo Treatment Unit and Instrument Business


The acquisition will strengthen Planmeca’s and KaVo’s positions as leading providers of innovative dental solutions and increase Planmeca Group’s annual revenue to more than EUR 1,1 billion, or about $1.3 billion.

Planmeca Oy Planning to Acquire KaVo Treatment Unit and Instrument Business

Two of the larger manufacturers of dental equipment and instruments look ready to join forces with news this week of Planmeca Oy’s plans to acquire the KaVo Treatment Unit & Instrument business from Envista Holdings Corporation.

The acquisition will complement Planmeca’s extensive product portfolio and enhance the growth and competitiveness of both companies, allowing them to offer the best possible modern digital workflow to dental professionals around the world.

KaVo Treatment Unit and Instruments is a renowned manufacturer and supplier of dental care units and instruments with a strong worldwide brand presence. The company’s treatment units include dental chairs, dental units and dentist stools featuring beautiful lines, patient comfort, and simple operation. Designed to provide everything you need to perform any procedure—all in 1 solution. KaVo’s new generation of treatment units are packed with smart, innovative features to boost productivity and deliver a state-of-the-art platform for technology integration.

Both companies will continue to operate as independent businesses, while future synergies will be sought in products, technology innovations and distribution network, according to a press release from Planmeca Oy on Sept. 7.

“This partnership will make us a very strong player in the dental field. I believe our companies are a great match–we share the same standards and passion for high technology, quality and innovation, and for offering a complete digital workflow for our customers. We also share similar company cultures with a strong family business heritage. Caring for our employees and focusing on our customers have always been important values for us both,” says Heikki Kyöstilä, the owner, founder and CEO of Planmeca Group.

“We have always had great admiration for KaVo as a premium brand. This partnership will allow us to provide exceptional value to both our customers and distributors. Our mission is to become the world’s leading provider of digital dental solutions,” states Tuomas Lokki, senior vice president of Planmeca Group.

The transaction is expected to close at the end of 2021. A 51 percent stake of the KaVo Treatment Unit and Instrument business will be acquired by Planmeca Oy, and the remaining 49 percent by Heikki Kyöstilä as a private individual. After acquisition completion, Planmeca Group will employ a total of 4,500 people worldwide.

Established in 1971, Planmeca Oy is celebrating its 50th anniversary this year.

Recent Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Dental Products Report Spring Selection Bracket Reveal Video
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Related Content
© 2024 MJH Life Sciences

All rights reserved.